Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe, Valentı́n Fuster, Anuradha Lala, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 1, pp. 122-124
Open Access | Times Cited: 944

Showing 1-25 of 944 citing articles:

Extrapulmonary manifestations of COVID-19
Aakriti Gupta, Mahesh V. Madhavan, Kartik Sehgal, et al.
Nature Medicine (2020) Vol. 26, Iss. 7, pp. 1017-1032
Open Access | Times Cited: 3022
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
Masataka Nishiga, Dao Wen Wang, Yaling Han, et al.
Nature Reviews Cardiology (2020) Vol. 17, Iss. 9, pp. 543-558
Open Access | Times Cited: 1301
Risk factors for severe and critically ill COVID‐19 patients: A review
Yadong Gao, Mei Ding, Xiang Dong, et al.
Allergy (2020) Vol. 76, Iss. 2, pp. 428-455
Open Access | Times Cited: 1282
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Aldo Bonaventura, Alessandra Vecchiè, Lorenzo Dagna, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 319-329
Open Access | Times Cited: 785
Effects of COVID-19 on the Nervous System
Costantino Iadecola, Josef Anrather, Hooman Kamel
Cell (2020) Vol. 183, Iss. 1, pp. 16-27.e1
Open Access | Times Cited: 645
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
Si Zhang, Yangyang Liu, Xiaofang Wang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 633
Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019
Lisa K. Moores, Tobias Tritschler, Shari B. Brosnahan, et al.
CHEST Journal (2020) Vol. 158, Iss. 3, pp. 1143-1163
Open Access | Times Cited: 615
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David Halpin, Gerard J. Criner, Alberto Papi, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 203, Iss. 1, pp. 24-36
Open Access | Times Cited: 612
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit
Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost, et al.
JAMA (2021) Vol. 325, Iss. 16, pp. 1620-1620
Open Access | Times Cited: 591
D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study
Yumeng Yao, Jiatian Cao, Qingqing Wang, et al.
Journal of Intensive Care (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 555
Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series
Amy Rapkiewicz, Xingchen Mai, Steven E. Carsons, et al.
EClinicalMedicine (2020) Vol. 24, pp. 100434-100434
Open Access | Times Cited: 535
Large-Scale Multi-omic Analysis of COVID-19 Severity
Katherine A. Overmyer, Evgenia Shishkova, Ian Miller, et al.
Cell Systems (2020) Vol. 12, Iss. 1, pp. 23-40.e7
Open Access | Times Cited: 531
Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
Celestino Sardu, Jessica Gambardella, Marco Bruno Morelli, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1417-1417
Open Access | Times Cited: 529
The unique characteristics of COVID-19 coagulopathy
Toshiaki Iba, Jerrold H. Levy, Jean M. Connors, et al.
Critical Care (2020) Vol. 24, Iss. 1
Open Access | Times Cited: 505
Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients With COVID-19
Girish N. Nadkarni, Anuradha Lala, Emilia Bagiella, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 16, pp. 1815-1826
Open Access | Times Cited: 449
COVID-19: Hemoglobin, Iron, and Hypoxia beyond Inflammation. A Narrative Review
Attilio Cavezzi, Emidio Troiani, Salvatore Corrao
Clinics and Practice (2020) Vol. 10, Iss. 2, pp. 1271-1271
Open Access | Times Cited: 413
Thrombosis risk associated with COVID-19 infection. A scoping review
Fatimah Al‐Ani, Samer Chehade, Alejandro Lazo‐Langner
Thrombosis Research (2020) Vol. 192, pp. 152-160
Open Access | Times Cited: 392
American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19
Adam Cuker, Eric Tseng, Robby Nieuwlaat, et al.
Blood Advances (2021) Vol. 5, Iss. 3, pp. 872-888
Open Access | Times Cited: 387
Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update
Waleed Alhazzani, Laura Evans, Fayez Alshamsi, et al.
Critical Care Medicine (2021) Vol. 49, Iss. 3, pp. e219-e234
Open Access | Times Cited: 360
Long-term complications of COVID-19
Amar D. Desai, Michael P. Lavelle, Brian C. Boursiquot, et al.
AJP Cell Physiology (2021) Vol. 322, Iss. 1, pp. C1-C11
Open Access | Times Cited: 350
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro
Paul S. Kwon, Hanseul Oh, Seok‐Joon Kwon, et al.
Cell Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 320
Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
Michelle Sholzberg, Grace H. Tang, Hassan Rahhal, et al.
BMJ (2021), pp. n2400-n2400
Open Access | Times Cited: 317
Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019
Jonathan H. Chow, Ashish K. Khanna, Shravan Kethireddy, et al.
Anesthesia & Analgesia (2020) Vol. 132, Iss. 4, pp. 930-941
Open Access | Times Cited: 304
Thrombosis in COVID‐19
Thomas C. Hanff, Amir M. Mohareb, Jay Giri, et al.
American Journal of Hematology (2020) Vol. 95, Iss. 12, pp. 1578-1589
Open Access | Times Cited: 295
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial
Florence Ader, Maude Bouscambert‐Duchamp, Maya Hites, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 209-221
Open Access | Times Cited: 295
Page 1 - Next Page

Scroll to top